The Drug Enforcement Agency (DEA) has temporarily lifted the ban against kratom as many individuals and groups have claimed that it is a great alternative for those who need treatment but without having to worry about being addicted to the substance. Adding kratom to the Schedule 1 list would define the plant as a drug with no currently accepted medical use and has a high potential for abuse.
The American Kratom Association said that the DEA was too rash in categorizing kratom as a dangerous and highly addictive drug like marijuana. DEA's decision in lifting the ban was a move that was highly regarded by the Botanical Education Alliance because it gives room for further studies on its beneficial effects and to prove that, although it can provide similar effects as those of other opiates, it will not pose any danger with regards to drug dependency and subsequent health issues.
If adding kratom to the list is pursued, the use would consequently be limited as well as further scientific studies for medical use. This would cause banning of the plant for at least two years, according to a news item.
DEA has announced that it will wait for recommendations coming from the Food and Drug Administration (FDA) and from public feedback before it can finally decide on the fate of the substance until December 1 of this year.
There are only six U.S. states ban kratom and its components, all of which remain legal under federal law. Wherever a Kratom ban exists, Kratom laboratory testing can be used.